Effect of inflammation on drug transporters; impact on maternal and fetal drug exposure

被引：0
|
作者：
Piquette-Miller, Micheline [1 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
来源：
DRUG METABOLISM REVIEWS | 2011年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [31] CONTROLLED BRAIN EXPOSURE OF OSELTAMIVIR BY DRUG TRANSPORTERS
    Morimoto, Kaori
    Shirasaka, Yoshiyuki
    Enomoto, Shigeki
    Yabuuchi, Hikaru
    Tamai, Ikumi
    Ogihara, Takuo
    DRUG METABOLISM REVIEWS, 2008, 40 : 212 - 213
  • [32] THE EFFECT OF THE BETA-MIMETIC DRUG CLENBUTEROL ON MATERNAL AND FETAL BEHAVIOR
    WLADIMIROFF, JW
    ROODENBURG, PJ
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 1982, 13 (02): : 67 - 74
  • [33] MATERNAL DRUG-THERAPY - EFFECT ON FETAL AND NEONATAL GROWTH AND NEUROBEHAVIOR
    HILL, RM
    TENNYSON, LM
    NEUROTOXICOLOGY, 1986, 7 (02) : 121 - 139
  • [34] Regulation of drug-metabolizing enzymes and transporters in inflammation
    Aitken, AE
    Richardson, TA
    Morgan, ET
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2006, 46 : 123 - 149
  • [35] FETAL DRUG EXPOSURE - BEHAVIORAL TERATOGENESIS
    GAL, P
    SHARPLESS, MK
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1984, 18 (03): : 186 - 201
  • [36] Impact of Maternal Environment and Inflammation on Fetal Neurodevelopment
    Lubrano, Chiara
    Parisi, Francesca
    Cetin, Irene
    ANTIOXIDANTS, 2024, 13 (04)
  • [37] Maternal use of drug substrates of placental transporters and the effect of transporter-mediated drug interactions on the risk of congenital anomalies
    Daud, Aizati N. A.
    Bergman, Jorieke E. H.
    Oktora, Monika P.
    Kerstjens-Frederikse, Wilhelmina S.
    Groen, Henk
    Bos, Jens H.
    Hak, Eelko
    Wilffert, Bob
    PLOS ONE, 2017, 12 (03):
  • [38] Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug-drug interactions
    Armani, Sara
    Geier, Andreas
    Forst, Thomas
    Merle, Uta
    Alpers, David H.
    Lunnon, Martin W.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (04) : 942 - 958
  • [39] Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment
    Stanke-Labesque, Francoise
    Gautier-Veyret, Elodie
    Chhun, Stephanie
    Guilhaumou, Romain
    PHARMACOLOGY & THERAPEUTICS, 2020, 215
  • [40] MATERNAL DRUG-THERAPY FOR FETAL DISORDERS
    WARD, RM
    SEMINARS IN PERINATOLOGY, 1992, 16 (01) : 12 - 20
12345